Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Am J Med. 2013 Oct;126(10):10.1016/j.amjmed.2013.04.021. doi: 10.1016/j.amjmed.2013.04.021

Table 3.

Other outcomes among the subset of AFFRIM patients 70 to 80 years with atrial fibrillation

Events (%)
Absolute
risk
difference*
Hazard ratio
(95% CI)
P
value
Outcomes Rate-control
strategy
(n=937)
Rhythm-control
strategy
(n=937)
Cardiovascular mortality 84 (9%) 92 (10%) 1% 0.88 (0.65–1.18) 0.39
  Due to cardiac causes 65 (7%) 74 (8%) 1% 0.85 (0.61–1.18) 0.33
   Arrhythmic 35 (4%) 45 (5%) 1% 0.75 (0.48–1.16) 0.20
   Non-arrhythmic 30 (3%) 29 (3%) 0% 1.00 (0.60–1.66) 1.00
  Due to vascular causes 19 (2%) 18 (2%) 0% 1.01 (0.53–1.93) 0.97
Non-cardiovascular mortality 70 (8%) 108 (12%) 4% 0.62 (0.46–0.84) 0.002
All-cause hospitalization 571 (61%) 641 (68%) 7% 0.76 (0.68–0.86) <0.001
  Cardiovascular 288 (31%) 387 (41%) 10% 0.66 (0.56–0.77) <0.001
  Non-cardiovascular 283 (30%) 254 (27%) 3% 1.07 (0.91–1.27) 0.42
Stroke 41 (4%) 44 (5%) 1% 0.90 (0.59–1.37) 0.61
Major bleeding** 78 (8%) 72 (8%) 0% 1.05 (0.77–1.45) 0.75
*

Absolute risk difference was calculated by subtracting the percentage of events in the rate control group from that in the rhythm control group.

**

Major bleeding was defined as bleeding requiring transfusion and/or surgery.